BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//White City Innovation District - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:White City Innovation District
X-ORIGINAL-URL:https://www.whitecityinnovationdistrict.org.uk
X-WR-CALDESC:Events for White City Innovation District
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20240925T153000
DTEND;TZID=Europe/London:20240925T183000
DTSTAMP:20260416T230402
CREATED:20240822T162312Z
LAST-MODIFIED:20240822T162312Z
UID:2947-1727278200-1727289000@www.whitecityinnovationdistrict.org.uk
SUMMARY:JAWDROP Fireside: Boosting Trust to Advance Health & UK Life Sciences
DESCRIPTION:Trust is a cornerstone of effective health systems\, influencing every interaction between the public and healthcare providers. This Jawdrop Fireside will explore how enhancing trust can lead to better public health outcomes and bolster the success of the UK Life Sciences sector. \nIt builds on previous Jawdrop themes\, such as optimising clinical trials and strengthening the UK’s resilience against antimicrobial resistance (AMR) and future pandemics and aims to delve into the pivotal role of trust more broadly including around health in local communities. \nPANEL 1: Engaging Communities and Building Trust for Vaccines \nChildhood vaccination rates in the UK have dipped\, with no vaccines meeting the 95% target and the country seeing a re-emergence of measles\, a previously eradicated illness. Globally\, the picture is mixed\, with rates for long standing vaccines including BCG and HepB3 falling\, others remaining stable or\, in the case of new vaccines\, inching up. \nIn the UK\, vaccine uptake has benefited through active public health campaigns. Yet\, such progress is threatened by factors including the easy and rapid spread of online disinformation. It is also hindered by the growing mistrust in government and dissatisfaction with the NHS. Our panel consists of public health practitioners\, vaccine-makers and academics\, all of whom seek to build strong relationships and trust\, through different channels and means. \nPanelists: \nDr Nicola Lang\, Director of Public Health for H&F Council \nDr Philip Cruz – Moderna UK\, Country Medical Director \nDr Andrew Cai\, Medical Director of UK and Republic of Ireland\, CSL Seqirus. \nPhayza Fudlulla\, BME Health Forum \nChair: Professor Helen Ward\, Professor of Public Health\, School of Public Health\, Imperial \nPANEL 2: Engaging Communities and Building Trust for Clinical Research \nClinical research is essential for advancing medical knowledge and developing new treatments. The 2022/23 CRN annual statistics show research participation levels have increased on pre-pandemic levels. Almost one million participants (952\,789) took part in clinical research across England. This is an increase of over 220\,000 on pre-pandemic levels. \nHowever\, patient trust in clinical research can be fragile\, influenced by factors such as past unethical studies\, lack of transparency\, and concerns about privacy and safety. In the UK\, a global hub for medical research\, initiatives to rebuild and enhance this trust are particularly crucial. London’s diverse population and advanced healthcare infrastructure make it an ideal setting for clinical trials\, but these same factors also present unique challenges. \nPanelists: \nNaima Adan\, Community Engagement Officer\, Patient Experience Research Centre (PERC) \nLuke Devey\, BMBCh\, Ph.D.\, Chief Medical Officer\, Quell Tx \nPauline Hakutangwi\, Novartis UK – patient engagement representative \nDr. Keerti Gedela\, EDI Lead\, CRN North West London \nCHAIR: Dr Bob Klaber\, Consultant General Paediatrician and Executive Director of Strategy\, Research and Innovation\, Imperial College Healthcare NHS Trust
URL:https://www.whitecityinnovationdistrict.org.uk/event/jawdrop-fireside-boosting-trust-to-advance-health-uk-life-sciences/
LOCATION:Molecular Sciences Research Hub (MSRH)\, 82 Wood Lane\, London\, W12 0BZ\, United Kingdom
ATTACH;FMTTYPE=image/jpeg:https://www.whitecityinnovationdistrict.org.uk/wp-content/uploads/sites/10/2024/08/Jawdrop-image_25.9.24.jpeg
ORGANIZER;CN="Upstream":MAILTO:hello@move-upstream.org.uk
END:VEVENT
END:VCALENDAR